Metoprolol: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) m (→Overview) |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | {{CMG}} | ||
===''[[Metoprolol succinate|Metoprolol Succinate]]''=== | ===''[[Metoprolol succinate|Metoprolol Succinate]]''=== | ||
| Line 34: | Line 22: | ||
* [[Lopressor HCT]] | * [[Lopressor HCT]] | ||
==Overview== | |||
Metoprolol is a competitive, [[Beta-1 adrenergic receptor|β<sub>1</sub>]]-selective (cardioselective) [[beta blocker|blocker]] used in treatment of [[angina pectoris]], [[hypertension]], [[arrhythmia]], and [[migraine]]. Common adverse reactions include [[bradyarrhythmia]], [[heart block]], [[heart failure]], [[hypotension]], [[pruritus]], [[rash]], [[constipation]], [[diarrhea]], [[indigestion]], [[nausea]], [[dizziness]], [[fatigue]], [[headache]], [[depression]], [[dyspnea]], and [[wheezing]]. | |||
The active substance metoprolol is employed either as ''metoprolol [[succinic acid|succinate]]'' or as ''metoprolol [[tartrate]]''. The [[tartrate]] is an immediate-release and the [[succinic acid|succinate]] is an extended-release [[Pharmaceutical formulation|formulation]]. | |||
==Category== | |||
Anti-anginal, antiarrhythmic, beta-adrenergic blocker | |||
Revision as of 16:12, 26 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Metoprolol Succinate
Metoprolol Succinate/Hydrochlorothiazide
Metoprolol Tartrate
Metoprolol Tartrate/Arginine
Metoprolol Tartrate/Hydrochlorothiazide
Overview
Metoprolol is a competitive, β1-selective (cardioselective) blocker used in treatment of angina pectoris, hypertension, arrhythmia, and migraine. Common adverse reactions include bradyarrhythmia, heart block, heart failure, hypotension, pruritus, rash, constipation, diarrhea, indigestion, nausea, dizziness, fatigue, headache, depression, dyspnea, and wheezing.
The active substance metoprolol is employed either as metoprolol succinate or as metoprolol tartrate. The tartrate is an immediate-release and the succinate is an extended-release formulation.
Category
Anti-anginal, antiarrhythmic, beta-adrenergic blocker